Aurobindo Pharma Limited: Detailed financials
Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.
Company financials
| Particulars | Dec-24 | Mar-25 | Jun-25 | Sep-25 | Dec-25 | Mar-26 | Jun-26 | Sep-26 |
|---|---|---|---|---|---|---|---|---|
| 7,979 | 8,382 | 7,868 | 8,286 | 8,646 | 8,853 | 9,150 | 10,263 | |
| 157 | 135 | 105 | 121 | 188 | 117 | 264 | 168 | |
| 6,938 | 7,150 | 6,769 | 7,132 | 7,430 | 7,677 | 7,858 | 8,741 | |
| 2,729 | 2,800 | 2,535 | 2,510 | 2,755 | 2,505 | 2,894 | 2,980 | |
| 824 | 636 | 808 | 846 | 893 | 931 | 932 | 914 | |
| −237 | −8 | −104 | −17 | −166 | −8 | −199 | 89 | |
| 1,132 | 1,163 | 1,229 | 1,277 | 1,310 | 1,374 | 1,480 | 1,659 | |
| 118 | 115 | 98 | 95 | 93 | 98 | 102 | 102 | |
| 419 | 444 | 406 | 429 | 465 | 479 | 487 | 531 | |
| 1,954 | 2,000 | 1,797 | 1,991 | 2,081 | 2,298 | 2,162 | 2,466 | |
| 1,735 | 1,927 | 1,708 | 1,799 | 1,896 | 1,870 | 2,105 | 2,324 | |
| 1,317 | 1,482 | 1,303 | 1,370 | 1,431 | 1,391 | 1,618 | 1,793 | |
| — | — | — | — | −65 | — | −40 | — | |
| 1,198 | 1,367 | 1,205 | 1,274 | 1,338 | 1,293 | 1,517 | 1,691 | |
| 354 | 432 | 383 | 428 | 429 | 370 | 483 | 564 | |
| 846 | 903 | 824 | 848 | 910 | 921 | 1,032 | 1,124 | |
| Financial ratios | ||||||||
| 21.75% | 22.99% | 21.71% | 21.71% | 21.93% | 21.12% | 23.01% | 22.64% | |
| 10.60% | 10.77% | 10.48% | 10.24% | 10.52% | 10.40% | 11.28% | 10.95% | |
| 14.56 | 15.56 | 14.20 | 14.61 | 15.67 | 15.86 | 17.86 | 19.57 | |
Revenue
₹ crore
Select any table row to compare its reported history.
Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.